SRHE:XETRA:XETRA-Amundi Index Solutions - Amundi Index MSCI EMU SRI PAB Ucits ETF DR Cap (EUR)

ETF | Others |

Last Closing

USD 87.9

Change

-0.15 (-0.17)%

Market Cap

USD 0.19B

Volume

108.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+1.07 (+2.05%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.35 (+2.04%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.44 (+1.61%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.44 (+1.54%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.42 (+1.68%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.04 (+0.03%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.86 (+1.91%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+1.08 (+2.07%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.78 (+1.71%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+9.98 (+1.66%)

USD 80.38B

ETFs Containing SRHE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.09% 59% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.09% 58% F 60% D-
Trailing 12 Months  
Capital Gain 12.09% 59% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.09% 58% F 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.15% 57% F 57% F
Dividend Return 8.15% 57% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.34% 75% C 80% B-
Risk Adjusted Return 111.02% 96% N/A 96% N/A
Market Capitalization 0.19B 44% F 40% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.